Company
Brise Pharmaceuticals Co., Ltd.
Brise Pharmaceuticals Co., Ltd. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| BR005-036C | Phase 3 | Migraine, With or Without Aura |
Latest
No recent events.
Follow Brise Pharmaceuticals Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.